News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,269 Results
Type
Article (44390)
Company Profile (440)
Press Release (681438)
Multimedia
Podcasts (94)
Webinars (16)
Section
Business (209402)
Career Advice (2063)
Deals (36122)
Drug Delivery (105)
Drug Development (84049)
Employer Resources (174)
FDA (16666)
Job Trends (15212)
News (354493)
Policy (33418)
Tag
Academia (2664)
Accelerated approval (14)
Adcomms (26)
Allergies (101)
Alliances (51238)
ALS (118)
Alzheimer's disease (1541)
Antibody-drug conjugate (ADC) (171)
Approvals (16651)
Artificial intelligence (337)
Autoimmune disease (34)
Automation (20)
Bankruptcy (373)
Best Places to Work (11894)
BIOSECURE Act (19)
Biosimilars (127)
Biotechnology (330)
Bladder cancer (101)
Brain cancer (36)
Breast cancer (391)
Cancer (3057)
Cardiovascular disease (237)
Career advice (1727)
Career pathing (30)
CAR-T (199)
CDC (34)
Cell therapy (540)
Cervical cancer (23)
Clinical research (69133)
Collaboration (1113)
Company closure (3)
Compensation (721)
Complete response letters (32)
COVID-19 (2701)
CRISPR (67)
C-suite (374)
Cystic fibrosis (123)
Data (3218)
Decentralized trials (2)
Denatured (33)
Depression (77)
Diabetes (355)
Diagnostics (6510)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (155)
Drug pricing (135)
Drug shortages (29)
Duchenne muscular dystrophy (159)
Earnings (89096)
Editorial (46)
Employer branding (21)
Employer resources (150)
Events (117837)
Executive appointments (891)
FDA (18476)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (998)
Gene editing (146)
Generative AI (24)
Gene therapy (432)
GLP-1 (837)
Government (4635)
Grass and pollen (5)
Guidances (220)
Healthcare (19308)
HIV (42)
Huntington's disease (31)
IgA nephropathy (44)
Immunology and inflammation (172)
Immuno-oncology (10)
Indications (42)
Infectious disease (2886)
Inflammatory bowel disease (158)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (128)
Interviews (318)
IPO (16897)
IRA (49)
Job creations (3730)
Job search strategy (1461)
Kidney cancer (13)
Labor market (55)
Layoffs (539)
Leadership (20)
Legal (8093)
Liver cancer (80)
Longevity (11)
Lung cancer (429)
Lymphoma (220)
Machine learning (12)
Management (58)
Manufacturing (430)
MASH (98)
Medical device (13756)
Medtech (13762)
Mergers & acquisitions (19967)
Metabolic disorders (896)
Multiple sclerosis (103)
NASH (19)
Neurodegenerative disease (150)
Neuropsychiatric disorders (42)
Neuroscience (2298)
NextGen: Class of 2025 (6826)
Non-profit (4586)
Now hiring (50)
Obesity (454)
Opinion (247)
Ovarian cancer (105)
Pain (128)
Pancreatic cancer (129)
Parkinson's disease (197)
Partnered (22)
Patents (324)
Patient recruitment (182)
Peanut (51)
People (59304)
Pharmaceutical (87)
Pharmacy benefit managers (22)
Phase I (21681)
Phase II (30471)
Phase III (22551)
Pipeline (1749)
Policy (219)
Postmarket research (2659)
Preclinical (9328)
Press Release (68)
Prostate cancer (151)
Psychedelics (44)
Radiopharmaceuticals (272)
Rare diseases (510)
Real estate (6046)
Recruiting (68)
Regulatory (23406)
Reports (50)
Research institute (2440)
Resumes & cover letters (360)
Rett syndrome (9)
RNA editing (12)
RSV (52)
Schizophrenia (99)
Series A (170)
Series B (119)
Service/supplier (11)
Sickle cell disease (68)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3799)
State (2)
Stomach cancer (15)
Supply chain (79)
Tariffs (64)
The Weekly (59)
Vaccines (832)
Venture capital (58)
Weight loss (280)
Women's health (49)
Worklife (17)
Date
Today (12)
Last 7 days (531)
Last 30 days (1772)
Last 365 days (31768)
2025 (18462)
2024 (36369)
2023 (41079)
2022 (52358)
2021 (56867)
2020 (55071)
2019 (47705)
2018 (35931)
2017 (33192)
2016 (32641)
2015 (38646)
2014 (32376)
2013 (27350)
2012 (29456)
2011 (30117)
2010 (28254)
Location
Africa (758)
Alabama (69)
Alaska (7)
Arizona (255)
Arkansas (14)
Asia (39979)
Australia (6668)
California (7828)
Canada (2450)
China (709)
Colorado (330)
Connecticut (343)
Delaware (204)
Europe (87813)
Florida (1167)
Georgia (260)
Hawaii (2)
Idaho (60)
Illinois (676)
India (28)
Indiana (374)
Iowa (19)
Japan (241)
Kansas (113)
Kentucky (31)
Louisiana (16)
Maine (64)
Maryland (1075)
Massachusetts (5917)
Michigan (252)
Minnesota (476)
Mississippi (4)
Missouri (96)
Montana (30)
Nebraska (25)
Nevada (85)
New Hampshire (71)
New Jersey (2186)
New Mexico (30)
New York (2170)
North Carolina (1172)
North Dakota (9)
Northern California (3443)
Ohio (245)
Oklahoma (16)
Oregon (39)
Pennsylvania (1687)
Puerto Rico (17)
Rhode Island (38)
South America (1129)
South Carolina (34)
South Dakota (1)
Southern California (2933)
Tennessee (128)
Texas (1192)
United States (29103)
Utah (226)
Virginia (198)
Washington D.C. (74)
Washington State (674)
West Virginia (4)
Wisconsin (72)
726,269 Results for "pain therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics
May 27, 2025
·
5 min read
Press Releases
Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain
July 15, 2025
·
7 min read
Press Releases
South Rampart Pharma Announces New Study in Neurobiology of Pain Demonstrating How SRP-001 Delivers Central, Non-Toxic Pain Relief
July 29, 2025
·
5 min read
Press Releases
Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025)
July 18, 2025
·
4 min read
Press Releases
Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain
June 5, 2025
·
4 min read
Press Releases
Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain
May 1, 2025
·
9 min read
Press Releases
Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management
June 5, 2025
·
7 min read
Press Releases
AlzeCure Presents ACD440 at the NeuPSIG 2025 Pain Conference
July 21, 2025
·
5 min read
Press Releases
Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
June 13, 2025
·
2 min read
Pain
Vertex’s Journavx Changes the Pain Treatment Landscape But Opioids Here to Stay
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a growing number of alternative approaches. Their ultimate uptake, however, remains to be seen.
February 24, 2025
·
9 min read
·
Tristan Manalac
1 of 72,627
Next
